ATE346914T1 - Udp-n-acetylglucosamin: galaktose-beta 1,3-n- acetylgalaktosamin-alpha-r/(glcnac -galnac) beta 1,6-n-acetylglucosaminyltransferase, c2gnt3 - Google Patents
Udp-n-acetylglucosamin: galaktose-beta 1,3-n- acetylgalaktosamin-alpha-r/(glcnac -galnac) beta 1,6-n-acetylglucosaminyltransferase, c2gnt3Info
- Publication number
- ATE346914T1 ATE346914T1 AT00954402T AT00954402T ATE346914T1 AT E346914 T1 ATE346914 T1 AT E346914T1 AT 00954402 T AT00954402 T AT 00954402T AT 00954402 T AT00954402 T AT 00954402T AT E346914 T1 ATE346914 T1 AT E346914T1
- Authority
- AT
- Austria
- Prior art keywords
- c2gnt3
- disclosed
- dna
- methods
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15048899P | 1999-08-24 | 1999-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE346914T1 true ATE346914T1 (de) | 2006-12-15 |
Family
ID=22534762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00954402T ATE346914T1 (de) | 1999-08-24 | 2000-08-24 | Udp-n-acetylglucosamin: galaktose-beta 1,3-n- acetylgalaktosamin-alpha-r/(glcnac -galnac) beta 1,6-n-acetylglucosaminyltransferase, c2gnt3 |
Country Status (11)
Country | Link |
---|---|
US (5) | US6635461B1 (de) |
EP (1) | EP1206529B1 (de) |
JP (1) | JP4642301B2 (de) |
AT (1) | ATE346914T1 (de) |
AU (1) | AU775990B2 (de) |
CA (1) | CA2384978C (de) |
DE (1) | DE60032150T2 (de) |
MX (1) | MXPA02001977A (de) |
NO (1) | NO20020813L (de) |
NZ (1) | NZ517219A (de) |
WO (1) | WO2001014535A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6593119B2 (en) | 2000-02-29 | 2003-07-15 | Glycodesign, Inc. | Core 2 β-1,6-N-acetylglycosaminyltransferase gene |
JP4300267B2 (ja) * | 2001-12-28 | 2009-07-22 | 独立行政法人産業技術総合研究所 | 新規n−アセチルグルコサミン転移酵素及びそれをコードする核酸 |
GB0329667D0 (en) * | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
GB0513881D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
US20080182801A1 (en) * | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
US20060216273A1 (en) * | 2005-03-25 | 2006-09-28 | Min-Chuan Huang | Gene therapy for colorectal cancer |
GB0512726D0 (en) * | 2005-06-22 | 2005-07-27 | Btg Int Ltd | Multiple sclerosis therapy and diagnosis |
GB0513883D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Diagnosis of Atherosclerosis |
GB0513888D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
JP2009511082A (ja) * | 2005-10-17 | 2009-03-19 | ヘルス リサーチ インコーポレイテッド | 糖類のためのトランスフェラーゼに特異的な受容体並びにその入手及び使用方法 |
WO2013015363A1 (ja) * | 2011-07-26 | 2013-01-31 | 独立行政法人産業技術総合研究所 | 上皮性卵巣癌マーカー検出用抗体及び上皮性卵巣癌判定方法 |
US9726668B2 (en) | 2012-02-09 | 2017-08-08 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
US10303846B2 (en) | 2014-08-14 | 2019-05-28 | Memed Diagnostics Ltd. | Computational analysis of biological data using manifold and a hyperplane |
EP3423590A4 (de) | 2016-03-03 | 2020-02-26 | Memed Diagnostics Ltd. | Rna-determinanten zur unterscheidung zwischen bakteriellen und viralen infektionen |
IL287757B (en) * | 2016-03-03 | 2022-07-01 | Memed Diagnostics Ltd | An RNA test to diagnose the type of infection |
CA3027341A1 (en) | 2016-07-10 | 2018-01-18 | Memed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
US11340223B2 (en) | 2016-07-10 | 2022-05-24 | Memed Diagnostics Ltd. | Early diagnosis of infections |
US11385241B2 (en) | 2016-09-29 | 2022-07-12 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
WO2018060999A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of risk assessment and disease classification |
CN108192978B (zh) * | 2018-03-29 | 2020-10-27 | 青岛泱深生物医药有限公司 | 一种肿瘤相关生物标志物及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60234574A (ja) * | 1984-05-08 | 1985-11-21 | 日本たばこ産業株式会社 | シガレツト製造機における中味たばこ量制御装置 |
AU4751990A (en) | 1988-12-13 | 1990-07-10 | La Jolla Cancer Research Foundation | Nucleotides encoding human b1, 4-galactosyltransferase and uses thereof |
US5360733A (en) | 1992-10-01 | 1994-11-01 | La Jolla Cancer Research Foundation | Human β1-6 n-acetylglucosaminyl transferase |
WO1995007020A1 (en) * | 1993-09-09 | 1995-03-16 | La Jolla Cancer Research Foundation | EXPRESSION OF THE DEVELOPMENTAL I ANTIGEN BY A CLONED HUMAN cDNA ENCODING A BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE |
US5484590A (en) * | 1993-09-09 | 1996-01-16 | La Jolla Cancer Research Foundation | Expression of the developmental I antigen by a cloned human cDNA encoding a member of a β-1,6-N-acetylglucosaminyltransferase gene family |
US6136580A (en) | 1999-01-19 | 2000-10-24 | The Burnham Institute | β-1-6-N-acetylglucosaminyltransferase that forms core 2, core 4 and I branches |
US6593119B2 (en) * | 2000-02-29 | 2003-07-15 | Glycodesign, Inc. | Core 2 β-1,6-N-acetylglycosaminyltransferase gene |
-
2000
- 2000-08-24 NZ NZ517219A patent/NZ517219A/en not_active IP Right Cessation
- 2000-08-24 CA CA2384978A patent/CA2384978C/en not_active Expired - Fee Related
- 2000-08-24 AT AT00954402T patent/ATE346914T1/de not_active IP Right Cessation
- 2000-08-24 AU AU66868/00A patent/AU775990B2/en not_active Ceased
- 2000-08-24 US US09/645,192 patent/US6635461B1/en not_active Expired - Lifetime
- 2000-08-24 MX MXPA02001977A patent/MXPA02001977A/es active IP Right Grant
- 2000-08-24 WO PCT/DK2000/000469 patent/WO2001014535A2/en active IP Right Grant
- 2000-08-24 DE DE60032150T patent/DE60032150T2/de not_active Expired - Lifetime
- 2000-08-24 EP EP00954402A patent/EP1206529B1/de not_active Expired - Lifetime
- 2000-08-24 JP JP2001518849A patent/JP4642301B2/ja not_active Expired - Fee Related
-
2002
- 2002-02-19 NO NO20020813A patent/NO20020813L/no not_active Application Discontinuation
- 2002-02-25 US US10/084,406 patent/US6794169B2/en not_active Expired - Fee Related
-
2003
- 2003-03-13 US US10/388,307 patent/US7094887B2/en not_active Expired - Fee Related
-
2004
- 2004-05-11 US US10/843,962 patent/US7097994B2/en not_active Expired - Fee Related
- 2004-05-11 US US10/843,723 patent/US7078206B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60032150T2 (de) | 2007-09-27 |
US7078206B2 (en) | 2006-07-18 |
JP4642301B2 (ja) | 2011-03-02 |
US7094887B2 (en) | 2006-08-22 |
MXPA02001977A (es) | 2002-09-18 |
EP1206529A2 (de) | 2002-05-22 |
NZ517219A (en) | 2004-06-25 |
US6794169B2 (en) | 2004-09-21 |
NO20020813L (no) | 2002-04-19 |
JP2003507061A (ja) | 2003-02-25 |
US6635461B1 (en) | 2003-10-21 |
US20040203092A1 (en) | 2004-10-14 |
AU775990B2 (en) | 2004-08-19 |
AU6686800A (en) | 2001-03-19 |
CA2384978C (en) | 2012-10-23 |
US20030054525A1 (en) | 2003-03-20 |
US7097994B2 (en) | 2006-08-29 |
EP1206529B1 (de) | 2006-11-29 |
WO2001014535A3 (en) | 2001-06-21 |
NO20020813D0 (no) | 2002-02-19 |
US20040203111A1 (en) | 2004-10-14 |
WO2001014535A2 (en) | 2001-03-01 |
US20030180778A1 (en) | 2003-09-25 |
CA2384978A1 (en) | 2001-03-01 |
DE60032150D1 (de) | 2007-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE346914T1 (de) | Udp-n-acetylglucosamin: galaktose-beta 1,3-n- acetylgalaktosamin-alpha-r/(glcnac -galnac) beta 1,6-n-acetylglucosaminyltransferase, c2gnt3 | |
EP1129179A4 (de) | UDP-Galaktose: BETA-I(N)-Acetyl-Glukosamin BETA1,3 Galaktosyltransferasen, BETA3Gal-T5 | |
Kytzia et al. | Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A. | |
Herscovics | Processing glycosidases of Saccharomyces cerevisiae | |
Viladot et al. | Probing the mechanism of Bacillus 1, 3-1, 4-β-D-glucan 4-glucanohydrolases by chemical rescue of inactive mutants at catalytically essential residues | |
Telkov et al. | Proteins of the Rpf (resuscitation promoting factor) family are peptidoglycan hydrolases | |
Finnis et al. | Thymidine phosphorylase activity of platelet‐derived endothelial cell growth factor is responsible for endothelial cell mitogenicity | |
DK0470145T3 (da) | Kartoffel-alfa-amylasegen | |
ATE302853T1 (de) | Pflanzliche (gnti)-sequenzen und verwendung derselben zur gewinnung von pflanzen mit verminderter oder fehlender n- acetylglucosaminyltransferase i (gnti)-aktivität | |
NO20021931L (no) | L-pantolacton-hydrolase og en fremgangsmåte for fremstilling av D-pantolacton | |
Horsburgh et al. | LytG of Bacillus subtilis is a novel peptidoglycan hydrolase: the major active glucosaminidase | |
Bakke et al. | Identification, characterization, and molecular cloning of a novel hyaluronidase, a member of glycosyl hydrolase family 16, from Penicillium spp. | |
Hartl et al. | Second naturally occurring β-galactosidase in E. coli | |
TWI245800B (en) | Endo-beta-N-acetylglucosaminidase gene | |
Chen et al. | A tetrad of ionizable amino acids is important for catalysis in barley β-glucanases | |
Filipowicz et al. | Cyclization of RNA 3'-terminal phosphate by cyclase from HeLa cells proceeds via formation of N (3') pp (5') A activated intermediate. | |
JP2005516594A (ja) | 可溶性GlcNAcホスフォトランスフェラーゼ | |
WO2003102194A1 (fr) | Chondroitine synthetase et codage de l'adn pour l'enzyme | |
Belaz et al. | Identification, biochemical characterization, and in-vivo expression of the intracellular invertase BfrA from the pathogenic parasite Leishmania major | |
Oshima et al. | Isolation and sequence of a novel amphibian pancreatic chitinase | |
Sakakibara et al. | Construction and expression of human aldolase A and B expression plasmids in Escherichia coli host | |
Suresh et al. | Evidence that the putative α-glucosidase of Thermotoga maritima MSB8 is a pNP α-D-glucuronopyranoside hydrolyzing α-glucuronidase | |
US20030129723A1 (en) | Thermophilic endoglucanase | |
ATE346913T1 (de) | Udp-n-acetyl glucosamin: galaktose-batel, 3-n- acetyl galaktosamin-alpha-r/ n-acetyl glucosamin- betal, 3-n-acetyl galaktosamin-alpha-r (glcnac to galnac) betal, 6-n-acetyl glucosaminyl transferase, c2/4gnt | |
Nakaya et al. | Changes of DNA ligase in developing rat brain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |